Friday, 24 th May 2024

Pfizer Breast Academy

1:30 PM Cairo Time

Speakers

Prof. Dr. Hamdy AbdelAzim

Faculty of Medicine, Cairo University, Department of Clinical Oncology Al-Kasr Al-Aini

Prof. Dr. Alaa Kandil

Faculty of Medicine, Alexandria University, Department of Clinical Oncology.

Prof. Dr. Emad Hamada

Faculty of Medicine, Cairo University, Department of Clinical Oncology Al-Kasr Al-Aini

Prof. Dr. Loay Kassem

Faculty of Medicine, Cairo University, Department of Clinical Oncology Al-Kasr Al-Aini

Prof. Dr. Emad Shash

Faculty of Medicine Cairo University, National cancer Institute.

Prof. Dr. Amr Shafik

Faculty of Medicine, Ain shams university University, Oncology department

Prof Dr. Tamer El Nahass

Faculty of Medicine, Cairo University, Department of Clinical Oncology Al-Kasr Al-Aini

Prof. Dr. Ahmed Hassan

Faculty of Medicine, Ain shams university University, Oncology department

Prof. Dr. Ahmed Magdy

Faculty of Medicine Cairo University, National cancer Institute.

Prof. Dr. Emad Barsoum

Faculty of Medicine Cairo University, Barsoum oncology center and oncology science school

M.Sc Mohamed Kamal

Chief Scientific officer at Omicsense. Technical & bioinformatics advisor at molecular pathology lab at 57357 hospital

Prof. Dr. Hamdy AbdelAzim

Faculty of Medicine, Cairo University, Department of Clinical Oncology Al-Kasr Al-Aini

Agenda

Time
Topic
Speaker
1:30–1:50 PM
Arrival Coffee Break
1:50–2:00 PM
Welcome & Meeting Introduction
Pfizer
Session 1:
Molecular overview of breast cancer (BC) & management landscape in luminal advanced disease.
Q&A discussion at the last 5 min of each talk.

Chairman: Dr Alaa Kandil

Moderators: Dr Tamer El Nahas & Dr Emad Shash

2:00–2:30 PM
Management of ER+ HER2- advanced BC : Biological features driving treatment decisions.
Dr Hamdy Abdel Azim
2:30–3:00 PM
Molecular classification & biomarker of BC subtypes.
M.Sc Mohamed Kamal
3:00–3:30 PM
Primary & secondary endocrine resistance in luminal Advanced BC.
Dr Emad Hamada
3:30–4:00 PM
Exploring the evolution of precision medicine in BC.
Dr Ahmed Magdy
4:00–4:30 PM
Test your knowledge 1.
Dr Loay Kassem
4:30–5:00 PM
Brunch
Session 2:
Recent updates & emerging treatment strategies in different BC subtypes.
Q&A discussion at the last 5 min of each talk.

Chairman: Dr Emad Hamada

Moderators: Dr Loay Kassem & Dr Amr Shafik

5:00–5:30 PM
SABC 2024: Spotlight updates in Advanced BC.
Dr Alaa Kandil
5:30–6:00 PM
How does RWD inform clinical decisions in the use of CDK4/6 inhibitors in luminal Advanced BC?
Dr Emad Shash
6:00–6:30 PM
Emerging role of TKI in treatment of HER2+ Advanced BC patients.
Dr Ahmed Hassan
6:30–7:00 PM
Recent advances in treatment landscape of gBRCA +ve HER2- Advanced BC.
Dr Tamer EL Nahass
7:00–7:30 PM
Coffee break
Session 3:
Therapy management in different molecular subtypes in advanced BC.
Q&A discussion at the last 5 min of each talk.

Chairman: Dr Ahmed Hassan

Moderators: Dr Loay Kassem & Dr Amr Shafik

7:30–8:00 PM
Test Your Knowledge 2
Dr Amr Shafik
8:00–8:30 PM
Adverse events management with targeted therapy in Advanced BC
Dr Emad Barsoum
8:30–9:00 PM
Dinner